Precision BioSciences, Inc.

NASDAQ:DTIL

9.6 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Operating Activities:
Net Income -42.527-111.637-30.602-109.006-92.877-46.037-21.102-8.251
Depreciation & Amortization 8.2559.00410.1979.8135.3172.3541.4350.64
Deferred Income Tax -1.3270-6.14300.022000
Stock Based Compensation 14.0419.19716.51413.7868.942.4530.4190
Change In Working Capital -41.48724.1119.584-2.014-2.357-10.507-5.09599.716
Accounts Receivables -0.181-0.2329.512-9.035-0.441-0.52300
Inventory 004.3058.0135.283-5.94600
Accounts Payables 1.5080.1530.867-1.4550.667-0.6730.8640.082
Other Working Capital -42.81424.1894.90.463-7.866-3.365-5.95999.634
Other Non Cash Items -21.06813.573-20.4030.0359.940.0140.1741.367
Operating Cash Flow -84.114-45.753-10.853-87.386-71.015-51.723-24.16992.274
Investing Activities:
Investments In Property Plant And Equipment -2.278-3.319-5.803-5.031-24.666-15.678-5.565-2.075
Acquisitions Net 8.10700000.0150.050
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites 0-3.319-0.75000.0150.050
Investing Cash Flow 5.829-3.319-5.803-5.031-24.666-15.663-5.515-2.075
Financing Activities:
Debt Repayment 0-19.805-2.50-39.55000
Common Stock Issued 5.38774.34560.4771.329135.1850.1710.0150.049
Common Stock Repurchased 000000-0.9520
Dividends Paid 00000000
Other Financing Activities 0.40140.44512.5441.32977.739107.7770.015-12.425
Financing Cash Flow 5.38794.98570.5211.329173.374107.777-0.937-12.376
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash -72.89845.91353.865-91.08877.69340.391-30.62177.823
Cash At End Of Period 116.678189.576143.66389.798180.886103.19362.80293.423